Published Date: 06 Mar 2023
Srinagar: Government Medical College (GMC) Srinagar will have a new principal as the government announced on Thursday March 3...
Read Full NewsTransforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols
Not surprisingly, trust in government health agencies for cancer info has dipped
Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC
News, features, and commentary about cancer-related issues
Observational study shows greater microplastic burden in patients with lung malignancy
Health news and commentary gathered by MedPage Today staff
The health ramifications of the attack persist
1.
NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.
2.
Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients
3.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
4.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
5.
Dramatic Increase in Active Surveillance Use for Prostate Cancer
1.
Immune Ecosystem Remodeling Within Solid Tumor Niches
2.
Emerging Methods in Hematology in Clinical Decision-Making
3.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
4.
Nuclear Medicine's Role in Battling Women's Cancers
5.
Demystifying the Mentzer Index: Understanding Its Importance in Inventory Management
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Blood Clotting Disorders Explained
2.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Should We Use DARA Up Front As First-Line Therapy in MM?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation